News

August 23, 2019August 23, 2019

Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows

News

Treatment with a combination of oral paclitaxel and encequidar led to higher and stronger response rates compared with standard paclitaxel intravenous therapy in women with metastatic breast cancer, topline data from ... Read more

August 21, 2019

FDA Approves Rozlytrek for Breast Cancer, Other Solid Tumors with Specific Gene Defect

News

The U.S. Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) as an oral treatment for adult and adolescent patients whose breast cancer and other solid tumors have a specific ... Read more

August 19, 2019

Phase 2 Trial of NeuVax Vaccine for HER2-positive DCIS Fully Enrolled, Sellas Announces

News

The Phase 2 trial evaluating Sellas Life Sciences‘ cancer vaccine NeuVax as a treatment for women with early stage HER2-positive ductal carcinoma in situ (DCIS), a non-invasive breast cancer, has completed ... Read more

August 16, 2019

Trial Testing Eftilagimod Alpha-Chemo Combo for HR-positive Advanced Breast Cancers Now Fully Enrolled

News

Immunotep has completed patient enrollment for its Phase 2b trial evaluating eftilagimod alpha (IMP321) — an investigational therapy that stimulates the immune system to fight cancer — in combination with ... Read more

August 14, 2019

Eagle Prepares Clinical Trials of New Form of Fulvestrant to Treat ER-positive Breast Cancer

News

Eagle Pharmaceuticals is preparing a pilot study that may pave the way for a pivotal clinical trial evaluating its new formulation of fulvestrant as a treatment for estrogen receptor (ER)-positive breast ... Read more

August 12, 2019August 26, 2019

Fujifilm’s New Imaging Option Can Enhance Accuracy of Breast Biopsy

News

Fujifilm Medical Systems USA has expanded its breast cancer imaging toolbox by releasing a new tomosynthesis option for its ASPIRE Cristalle mammography technology, which improves accuracy of breast biopsy. The ... Read more

August 9, 2019

Test Being Developed to Determine Risk of Recurrence in Triple-negative Breast Cancer

News

A new test — based on genetic markers of immune response and with potential to be assayed in tumor biopsies — holds promise for identifying patients with triple-negative breast cancer ... Read more

August 7, 2019September 10, 2019

Keytruda Plus Chemo Increases Percentage of TNBC Patients With No Cancer Signs, Interim Analysis Shows

News

Using Keytruda (pembrolizumab) in combination with chemotherapy increased the percentage of patients showing no signs of breast cancer after completing a course of neoadjuvant therapy — treatment to shrink a ... Read more

August 5, 2019September 10, 2019

First Generic Version of Navelbine Launched in Europe for Breast, Lung Cancers

News

Lotus Pharmaceuticals has launched the first generic version of Pierre Fabre’s Navelbine (vinorelbine) in soft capsule form in Europe for the treatment of advanced breast cancer and advanced non-small-cell lung ... Read more

August 2, 2019

Verzenio-Faslodex Combo Prolongs Survival in Advanced Breast Cancer, Interim Phase 3 Data Show

News

Verzenio (abemaciclib) in combination with Faslodex (fulvestrant) prolongs the survival of women with HR-positive, HER2-negative advanced or metastatic breast cancer who had been previously treated with endocrine therapy, interim analysis ... Read more